Shandong province-based biologics and biopharmaceutical contract development and manufacturing organization (CDMO) MabPlex has raised RMB400 million ($59 million) in Series A funding led by SDIC Venture Capital and Shenzhen Capital Group.
Founded in 2013, MabPlex offers biologics development and manufacturing services for global drug companies from the pre-clinical stage to commercial launch. Focus areas include antibody-drug conjugates...
Legend Capital has absorbed lessons from its corporate sponsor to build a diversified investment business across the US dollar and renminbi spaces. It is now trying to take LP relations to a new level
Cerberus Capital Management has agreed to acquire the operating assets of bankrupt Australian equipment finance specialist Axsesstoday.
Sodexo Ventures, the venture capital arm of French food and facilities management services conglomerate Sodexo, has made its second investment in China, committing an undisclosed amount to technology-enabled catering service Meican.
Global Brain has led a $7.8 million round for Idein, a Japanese technology developer focused on systems for device-level data processing, also known as edge computing.